⌘K

Login Start Free

Home/Filings/4/0001144204-17-048725

4//SEC Filing

Akers Joseph A 4

Accession 0001144204-17-048725

CIK 0000910267other

View on SEC.gov Company Profile

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 6:26 PM ET

Size

5.2 KB

Accession

0001144204-17-048725

Insider Transaction Report

Form 4

Period: 2017-09-15

TITAN PHARMACEUTICALS INCTTNP

Director

Transactions

Award
Option to Purchase Common Stock
2017-09-15+10,000→ 10,000 total
Exercise: $1.50Exp: 2027-09-15→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]The option vests in 12 equal monthly installments commencing as of September 1, 2017.

Documents

1 file

4
v475383_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

TITAN PHARMACEUTICALS INC

CIK 0000910267

Entity typeother

Related Parties

1

filerCIK 0001379888

Filing Metadata

Form type: 4
Filed: Sep 18, 8:00 PM ET
Accepted: Sep 19, 6:26 PM ET
Size: 5.2 KB

View on SEC.gov